The cost of influenza in Thailand

The cost of influenza in less wealthy tropical countries is needed to inform national vaccine policy decisions. Between September 2003 and August 2004, we prospectively identified hospitalized pneumonia cases and outpatients with laboratory confirmed influenza in a Thai province. Disease incidence,...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Vaccine Ročník 24; číslo 20; s. 4417 - 4426
Hlavní autoři: Simmerman, James Mark, Lertiendumrong, Jongkol, Dowell, Scott F., Uyeki, Timothy, Olsen, Sonja J., Chittaganpitch, Malinee, Chunsutthiwat, Supamit, Tangcharoensathien, Viroj
Médium: Journal Article
Jazyk:angličtina
Vydáno: Oxford Elsevier Ltd 15.05.2006
Elsevier
Elsevier Limited
Témata:
Applied microbiology
Biological and medical sciences
Cost of Illness
Fundamental and applied biological sciences. Psychology
Hospitalization
Hospitals
Humans
Immunization
Influenza
Influenza Vaccines - administration & dosage
Influenza Vaccines - economics
Influenza virus
Influenza, Human - economics
Medical Audit
Microbiology
Pneumonia, Viral - economics
Prospective Studies
Thailand
Vaccines
Vaccines, antisera, therapeutical immunoglobulins and monoclonal antibodies (general aspects)
Thailand
Asia
Hong Kong China
China
Thailand
Influenza
Cost of illness
Infection
Viral disease
ISSN:0264-410X, 1873-2518
On-line přístup:Získat plný text
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!
Popis
Shrnutí:The cost of influenza in less wealthy tropical countries is needed to inform national vaccine policy decisions. Between September 2003 and August 2004, we prospectively identified hospitalized pneumonia cases and outpatients with laboratory confirmed influenza in a Thai province. Disease incidence, patient interviews, medical record reviews, and data from a national health survey were used to calculate direct and indirect costs which were extrapolated to the Thai population. Influenza was identified in 80 (11%) of 761 hospitalized pneumonia inpatients with projected annual incidence of 18–111/100,000 population. Influenza was confirmed in 23% of 1092 outpatients with an estimated annual incidence of 1420/100,000 population. Influenza was estimated to cause between US$ 23.4 and US$ 62.9 million in economic losses with lost productivity accounting for 56% of all costs. The burden of influenza in Thailand is greater than previously appreciated, particularly in young children and the elderly. The impact and cost-effectiveness of influenza vaccination for high-risk groups merits further investigation.
Bibliografie:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
content type line 23
ISSN:0264-410X
1873-2518
DOI:10.1016/j.vaccine.2005.12.060